Pendal Group LTD Emergent Bio Solutions Inc. Call Options Transaction History
Pendal Group LTD
- $12.2 Billion
- Q4 2022
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|---|---|---|---|---|
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding EBS
# of Institutions
177Shares Held
37.7MCall Options Held
94.1KPut Options Held
153K-
Black Rock Inc. New York, NY3.84MShares$21.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$17.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.5MShares$13.7 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO2.3MShares$12.6 Million0.01% of portfolio
-
State Street Corp Boston, MA1.71MShares$9.39 Million0.0% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $274M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...